HSH2D
Hematopoietic SH2 domain-containing protein
Also known as: ALX, FLJ14886, HSH2, HSH2D_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96JZ2
- Gene
- HSH2D
- Ensembl
- ENSG00000196684
- Chromosome
- 19
- Canonical length
- 352 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Focal adhesion sites,Cytosol
OverviewNCBI Gene
T-cell activation requires 2 signals: recognition of antigen by the T-cell receptor (see TCR; MIM 186880) and a costimulatory signal provided primarily by CD28 (MIM 186760) in naive T cells. HSH2 is a target of both of these signaling pathways (Greene et al., 2003 [PubMed 12960172]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
352 residues, UniProt reviewed canonical sequence.
>Q96JZ2|HSH2D
1 MTEAGKLPLP LPPRLDWFVH TQMGQLAQDG VPEWFHGAIS REDAENLLES QPLGSFLIRV
61 SHSHVGYTLS YKAQSSCCHF MVKLLDDGTF MIPGEKVAHT SLDALVTFHQ QKPIEPRREL
121 LTQPCRQKDP ANVDYEDLFL YSNAVAEEAA CPVSAPEEAS PKPVLCHQSK ERKPSAEMNR
181 ITTKEATSSC PPKSPLGETR QKLWRSLKML PERGQRVRQQ LKSHLATVNL SSLLDVRRST
241 VISGPGTGKG SQDHSGDPTS GDRGYTDPCV ATSLKSPSQP QAPKDRKVPT RKAERSVSCI
301 EVTPGDRSWH QMVVRALSSQ ESKPEHQGLA EPENDQLPEE YQQPPPFAPG YCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HSH2D can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 44 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 44 nTPM
- spleen: 36 nTPM
- tonsil: 34 nTPM
- lymph node: 25 nTPM
- small intestine: 19 nTPM
- appendix: 16 nTPM
Single-cell type
- plasma cells: 227 nCPM
- thymocytes: 207 nCPM
- nk-cells: 206 nCPM
- hematopoietic stem cells: 133 nCPM
- megakaryocyte-erythroid progenitors: 112 nCPM
- b-cells: 100 nCPM
Immune cell
- basophil: 233 nTPM
- neutrophil: 183 nTPM
- eosinophil: 101 nTPM
- NK-cell: 85 nTPM
- memory B-cell: 57 nTPM
- non-classical monocyte: 39 nTPM
Brain region
- white matter: 9 nTPM
- medulla oblongata: 6.5 nTPM
- cerebral cortex: 6.4 nTPM
- choroid plexus: 5.8 nTPM
- basal ganglia: 5.5 nTPM
- pons: 5.5 nTPM
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of B cell apoptotic process
- negative regulation of mitochondrial depolarization
- signal transduction
- T cell activation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SH2 domain
- SH2 domain superfamily
- SH2 domain
- Hematopoietic SH2 domain-containing protein, Src homology 2 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HSH2D in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HSH2D as an antibody target. Whether an autoantibody or antibody against HSH2D could matter depends on whether native HSH2D is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HSH2D is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HSH2D as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...